Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
Clinical trial NCT07586813 · RECRUITING
Trial details
- NCT number
- NCT07586813
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2027-10-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.